149 related items for PubMed ID: 2559616
1. [A clinical study of congenital adrenal hyperplasia].
Nanbu A, Kumamoto Y, Tachiki H, Itoh N, Mikuma N, Tsunekawa T, Takagi Y, Maruta H.
Hinyokika Kiyo; 1989 Nov; 35(11):1831-7. PubMed ID: 2559616
[Abstract] [Full Text] [Related]
2. [Treatment of virilizing adrenal hyperplasia in adolescents. Use and side-effects of dexamethasone].
Job JC, Munck A, Chaussain JL, Canlorbe P.
Arch Fr Pediatr; 1985 Nov; 42(9):765-9. PubMed ID: 4083978
[Abstract] [Full Text] [Related]
3. [Puberty and growth development in patients with a 21-hydroxylase defect].
Börger D, Willig RP.
Monatsschr Kinderheilkd; 1985 Nov; 133(11):828-33. PubMed ID: 2934617
[Abstract] [Full Text] [Related]
4. Obesity among children and adolescents with classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency.
Völkl TM, Simm D, Beier C, Dörr HG.
Pediatrics; 2006 Jan; 117(1):e98-105. PubMed ID: 16396852
[Abstract] [Full Text] [Related]
5. Growth patterns and outcomes in congenital adrenal hyperplasia; effect of chronic treatment regimens.
Rasat R, Espiner EA, Abbott GD.
N Z Med J; 1995 Aug 11; 108(1005):311-4. PubMed ID: 7644165
[Abstract] [Full Text] [Related]
6. [Medroxyprogesterone acetate. Contributive treatment in congenital adrenal hyperplasia caused by 21-hydroxylase deficiency in children].
La Selve H, Sempé M, Morel Y, Forest MG, de Peretti E, David M.
Arch Fr Pediatr; 1985 Aug 11; 42(7):511-6. PubMed ID: 2935112
[Abstract] [Full Text] [Related]
7. A comparison of three glucocorticoid suppressive regimes in adults with congenital adrenal hyperplasia.
Horrocks PM, London DR.
Clin Endocrinol (Oxf); 1982 Dec 11; 17(6):547-56. PubMed ID: 6299623
[Abstract] [Full Text] [Related]
8. [Pseudo- and central precocious puberty due to adrenogenital syndrome].
Pouw IS, Drop SL, Ladée-Levy JV, Slijper FM.
Tijdschr Kindergeneeskd; 1986 Jun 11; 54(3):77-83. PubMed ID: 2944246
[Abstract] [Full Text] [Related]
9. Repeated successful induction of fertility after replacing hydrocortisone with dexamethasone in a patient with congenital adrenal hyperplasia and testicular adrenal rest tumors.
Claahsen-van der Grinten HL, Otten BJ, Sweep FC, Hermus AR.
Fertil Steril; 2007 Sep 11; 88(3):705.e5-8. PubMed ID: 17517401
[Abstract] [Full Text] [Related]
10. Gender related differences in glucocorticoid therapy and growth outcomes among pubertal children with 21-hydroxylase deficiency congenital adrenal hyperplasia (CAH).
Deslauriers JR, Lenz AM, Root AW, Diamond FB, Bercu BB.
J Pediatr Endocrinol Metab; 2012 Sep 11; 25(9-10):977-81. PubMed ID: 23426829
[Abstract] [Full Text] [Related]
11. Final height of patients with classical congenital adrenal hyperplasia.
Aycan Z, Akbuğa S, Cetinkaya E, Ocal G, Berberoğlu M, Evliyaoğlu O, Adiyaman P.
Turk J Pediatr; 2009 Sep 11; 51(6):539-44. PubMed ID: 20196386
[Abstract] [Full Text] [Related]
12. Impact of hydrocortisone on adult height in congenital adrenal hyperplasia-the Minnesota cohort.
Sarafoglou K, Addo OY, Turcotte L, Otten N, Wickremasinghe A, Pittock S, Kyllo J, Lteif AN, Himes JH, Miller BS.
J Pediatr; 2014 May 11; 164(5):1141-1146.e1. PubMed ID: 24560184
[Abstract] [Full Text] [Related]
13. Rat prostatic weight regression in reaction to ketoconazole, cyproterone acetate, and RU 23908 as adjuncts to a depot formulation of gonadotropin-releasing hormone analogue.
Lamberts SW, Uitterlinden P, de Jong FH.
Cancer Res; 1988 Nov 01; 48(21):6063-8. PubMed ID: 2844399
[Abstract] [Full Text] [Related]
14. [Value of the assay of plasma steroids in the control of congenital adrenal hyperplasia].
Theintz GE, Sizonenko PC.
Arch Fr Pediatr; 1985 Mar 01; 42(3):211-7. PubMed ID: 4004483
[Abstract] [Full Text] [Related]
15. [Acute complications during treatment of virilizing congenital adrenal hyperplasia deficiency due to 21-hydroxylase].
Job JC, Canlorbe P, Lambertz J, Courouble P, Rossier A.
Ann Pediatr (Paris); 1970 Mar 01; 17(6):426-31. PubMed ID: 5421325
[No Abstract] [Full Text] [Related]
16. [Hypophyseal-adrenal regulation in congenital adrenal hyperplasia (study of plasma corticotropic activity in 24 patients)].
Binoux M, Girard F, Pham-Huu-Trung MT, Canlorbe P, Mozziconacci P.
Arch Fr Pediatr; 1967 Apr 01; 24(4):369-97. PubMed ID: 4294851
[No Abstract] [Full Text] [Related]
17. Growth and precocious puberty.
Chaussain JL, Couprie C, Lacaille F, Simon D, Job JC.
Acta Paediatr Scand Suppl; 1988 Apr 01; 347():38-43. PubMed ID: 2978196
[Abstract] [Full Text] [Related]
18. [Present state of diagnosis and treatment of the adrenogenital syndrome (author's transl)].
Teller WM.
Klin Padiatr; 1975 Nov 01; 187(6):477-83. PubMed ID: 1240549
[Abstract] [Full Text] [Related]
19. Linear growth rate, bone maturation and growth hormone secretion in prepubertal children with congenital adrenal hyperplasia.
Rappaport R, Bouthreuil E, Marti-Henneberg C, Basmaciogullari A.
Acta Paediatr Scand; 1973 Sep 01; 62(5):513-9. PubMed ID: 4754146
[No Abstract] [Full Text] [Related]
20. Growth patterns in the first three years of life in children with classical congenital adrenal hyperplasia diagnosed by newborn screening and treated with low doses of hydrocortisone.
Bonfig W, Schmidt H, Schwarz HP.
Horm Res Paediatr; 2011 Sep 01; 75(1):32-7. PubMed ID: 20714115
[Abstract] [Full Text] [Related]
Page: [Next] [New Search]
